German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer. [electronic resource]
Producer: 20131126Description: 3531-9 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Capecitabine
- Carcinoma, Ductal, Breast -- drug therapy
- Carcinoma, Lobular -- drug therapy
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Deoxycytidine -- administration & dosage
- Diphosphonates -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Germany
- Humans
- Ibandronic Acid
- Middle Aged
- Neoplasm Grading
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Prognosis
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.